General Information of Drug Off-Target (DOT) (ID: OTD4K3PQ)

DOT Name MORF4 family-associated protein 1-like 1 (MRFAP1L1)
Gene Name MRFAP1L1
UniProt ID
MR1L1_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Pfam ID
PF15155
Sequence
MRPLDIDEVEAPEEVEVLEPEEDFEQFLLPVINEMREDIASLIREHGRAYLRTRSKLWEM
DNMLIQIKTQVEASEESALNHVQHPSGEADERVSELCEKAEEKAKEIAKMAEMLVELVWR
IERSESS

Molecular Interaction Atlas (MIA) of This DOT

Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
2 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate decreases the methylation of MORF4 family-associated protein 1-like 1 (MRFAP1L1). [1]
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene decreases the methylation of MORF4 family-associated protein 1-like 1 (MRFAP1L1). [5]
------------------------------------------------------------------------------------
5 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Ciclosporin DMAZJFX Approved Ciclosporin decreases the expression of MORF4 family-associated protein 1-like 1 (MRFAP1L1). [2]
Doxorubicin DMVP5YE Approved Doxorubicin increases the expression of MORF4 family-associated protein 1-like 1 (MRFAP1L1). [3]
Cupric Sulfate DMP0NFQ Approved Cupric Sulfate decreases the expression of MORF4 family-associated protein 1-like 1 (MRFAP1L1). [4]
Leflunomide DMR8ONJ Phase 1 Trial Leflunomide decreases the expression of MORF4 family-associated protein 1-like 1 (MRFAP1L1). [6]
Milchsaure DM462BT Investigative Milchsaure decreases the expression of MORF4 family-associated protein 1-like 1 (MRFAP1L1). [7]
------------------------------------------------------------------------------------

References

1 Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018 Jan 15;393:160-170.
2 Integrating multiple omics to unravel mechanisms of Cyclosporin A induced hepatotoxicity in vitro. Toxicol In Vitro. 2015 Apr;29(3):489-501.
3 Bringing in vitro analysis closer to in vivo: studying doxorubicin toxicity and associated mechanisms in 3D human microtissues with PBPK-based dose modelling. Toxicol Lett. 2018 Sep 15;294:184-192.
4 Physiological and toxicological transcriptome changes in HepG2 cells exposed to copper. Physiol Genomics. 2009 Aug 7;38(3):386-401.
5 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
6 Endoplasmic reticulum stress and MAPK signaling pathway activation underlie leflunomide-induced toxicity in HepG2 Cells. Toxicology. 2017 Dec 1;392:11-21.
7 Transcriptional profiling of lactic acid treated reconstructed human epidermis reveals pathways underlying stinging and itch. Toxicol In Vitro. 2019 Jun;57:164-173.